[Dermatology - Latest developments in targeted therapies for atopic dermatitis, alopecia areata and chronic

Aurélie Piletta-Zanin1, Aurélie Hsieh2, Michael Mühlstädt2

  • 1Faculté de médecine, Université de Genève, 1211 Genève 4.

Revue Medicale Suisse
|February 2, 2022
PubMed

Insights

New targeted therapies offer hope for atopic dermatitis, alopecia areata, and chronic spontaneous urticaria. Advanced treatments like JAK inhibitors and specific antibodies are improving patient quality of life.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • The rapid development of targeted therapies presents challenges in staying current.
  • Atopic dermatitis, alopecia areata, and chronic spontaneous urticaria are significant dermatological conditions.

Purpose of the Study:

  • To review the latest advancements in targeted therapies for atopic dermatitis, alopecia areata, and chronic spontaneous urticaria.
  • To highlight the efficacy and potential of novel treatment options.

Main Methods:

  • Literature review of recent clinical studies and therapeutic developments.
  • Analysis of targeted therapies including monoclonal antibodies and small molecule inhibitors.

Main Results:

  • Anti-interleukin-4 (IL-4) and anti-interleukin-13 (IL-13) antibodies, along with Janus kinase (JAK) inhibitors, show efficacy in moderate to severe atopic dermatitis.
  • JAK inhibitors demonstrate promise for severe alopecia areata.
  • Ligelizumab and nemolizumab present new therapeutic avenues for chronic spontaneous urticaria and prurigo, respectively.

Conclusions:

  • Recent breakthroughs in targeted therapies are significantly improving treatment options for debilitating skin conditions.
  • These novel treatments offer enhanced quality of life for patients, though cost remains a consideration.

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.2K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
651
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
651
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
742